Literature DB >> 29218246

Angiopoietin-like protein 2 facilitates non-small cell lung cancer progression by promoting the polarization of M2 tumor-associated macrophages.

Xiaojuan Wei1, Siyue Nie1, Hui Liu1, Jingyu Sun2, Jie Liu1, Juan Li1, Shuyan Li1, Shuyun Wang1, Shuyi Han3, Jun Wang3, Yuping Sun1.   

Abstract

The functional phenotypes (M1 and M2) of tumor-associated macrophages (TAMs) are influenced by the tumor microenvironment (TME) and contribute greatly to the development of non-small cell lung cancer (NSCLC). However, the molecular mechanisms for TAM polarization remain unclear. Angiopoietin-like protein 2 (Angptl2) is involved in tumor progression. In this study, Angptl2 expression was aberrantly increased in NSCLC cells and positively correlated with TAM infiltration, tumor size and poor patient survival. Moreover, in vitro tumor cell-macrophage co-culture and recombinant protein stimulation revealed that Angptl2 fostered the M2 polarization of TAMs through the p65 nuclear factor-kappa B (NF-ĸB) pathway. In addition, Angptl2-promoted TAM enhanced proliferation, invasion, and migration of NSCLC cells and the tube formation of human umbilical vein endothelial cells (HUVECs). In vivo, TAM depletion inhibited the tumor growth induced by Angptl2. Here, for the first time, we determined that Angptl2 promoted the M2 polarization of TAMs and enhanced NSCLC progression. Interfering with Angptl2 might be an effective strategy for reprogramming TAM polarization in NSCLC, providing a promising therapy for NSCLC treatment.

Entities:  

Keywords:  Angptl2; M2 macrophages; NF-ĸB; NSCLC; tumor progression

Year:  2017        PMID: 29218246      PMCID: PMC5714751     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  36 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis.

Authors:  Motoyoshi Endo; Masahiro Nakano; Tsuyoshi Kadomatsu; Shigetomo Fukuhara; Hiroaki Kuroda; Shuji Mikami; Tai Hato; Jun Aoi; Haruki Horiguchi; Keishi Miyata; Haruki Odagiri; Tetsuro Masuda; Masahiko Harada; Hirotoshi Horio; Tsunekazu Hishima; Hiroaki Nomori; Takaaki Ito; Yutaka Yamamoto; Takashi Minami; Seiji Okada; Takashi Takahashi; Naoki Mochizuki; Hirotaka Iwase; Yuichi Oike
Journal:  Cancer Res       Date:  2012-02-16       Impact factor: 12.701

3.  Suppression of experimental colitis by intestinal mononuclear phagocytes.

Authors:  Joseph E Qualls; Alan M Kaplan; Nico van Rooijen; Donald A Cohen
Journal:  J Leukoc Biol       Date:  2006-08-03       Impact factor: 4.962

4.  Diagnostic and Prognostic Value of Serum Angiopoietin-Like Protein 2 in Patients with Non-Small Cell Lung Cancer.

Authors:  Yinan Chen; Hailin Jiang; Lin Zhu; Peng Wang; Shiyuan Liu; Xiangsheng Xiao; Hong Yu; Weihua Dong
Journal:  Clin Lab       Date:  2017-01-01       Impact factor: 1.138

5.  Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria.

Authors:  Frank A W Verreck; Tjitske de Boer; Dennis M L Langenberg; Marieke A Hoeve; Matthijs Kramer; Elena Vaisberg; Robert Kastelein; Arend Kolk; René de Waal-Malefyt; Tom H M Ottenhoff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

Review 6.  Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications.

Authors:  N Van Rooijen; A Sanders
Journal:  J Immunol Methods       Date:  1994-09-14       Impact factor: 2.303

7.  Targeting NFKB by autophagy to polarize hepatoma-associated macrophage differentiation.

Authors:  Chih-Peng Chang; Yu-Chi Su; Pei-Huan Lee; Huan-Yao Lei
Journal:  Autophagy       Date:  2013-01-29       Impact factor: 16.016

8.  Angiopoietin Like Protein 2 (ANGPTL2) Promotes Adipose Tissue Macrophage and T lymphocyte Accumulation and Leads to Insulin Resistance.

Authors:  Yusuke Sasaki; Masayuki Ohta; Dhruv Desai; Jose-Luiz Figueiredo; Mary C Whelan; Tomohiro Sugano; Masaki Yamabi; Wataru Yano; Tyler Faits; Katsumi Yabusaki; Hengmin Zhang; Andrew K Mlynarchik; Keisuke Inoue; Ken Mizuno; Masanori Aikawa
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

9.  ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells.

Authors:  Xiaoye Liu; Xiaoting Yu; Jingjing Xie; Mengna Zhan; Zhuo Yu; Li Xie; Hongxiang Zeng; Feifei Zhang; Guoqiang Chen; Xianghua Yi; Junke Zheng
Journal:  Oncotarget       Date:  2015-08-28

10.  Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype.

Authors:  Thorsten Hagemann; Julia Wilson; Frances Burke; Hagen Kulbe; Ninfeng Fiona Li; Annette Plüddemann; Kellie Charles; Siamon Gordon; Frances R Balkwill
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

View more
  8 in total

Review 1.  Phosphoinositide 3-kinase/Akt and its related signaling pathways in the regulation of tumor-associated macrophages polarization.

Authors:  Depeng Yang; Lijun Yang; Jialing Cai; Huaxin Li; Zheng Xing; Ying Hou
Journal:  Mol Cell Biochem       Date:  2022-05-19       Impact factor: 3.842

2.  Genomic Copy Number Variants in CML Patients With the Philadelphia Chromosome (Ph+): An Update.

Authors:  Heyang Zhang; Meng Liu; Xiaoxue Wang; Yuan Ren; Young Mi Kim; Xianfu Wang; Xianglan Lu; Hui Pang; Guangming Liu; Yue Gu; Mingran Sun; Yunpeng Shi; Chuan Zhang; Yaowen Zhang; Jianqin Zhang; Shibo Li; Lijun Zhang
Journal:  Front Genet       Date:  2021-08-10       Impact factor: 4.599

3.  Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity.

Authors:  Aiqin Gao; Xia Liu; Wenli Lin; Jingnan Wang; Shuyun Wang; Fusheng Si; Lan Huang; Yangjing Zhao; Yuping Sun; Guangyong Peng
Journal:  J Immunother Cancer       Date:  2021-03       Impact factor: 13.751

4.  Expression of ANGPTL2 and its impact on papillary thyroid cancer.

Authors:  Longyan Yang; Rongxin Sun; Yan Wang; Ying Fu; Yuanyuan Zhang; Zhaohui Zheng; Zhili Ji; Dong Zhao
Journal:  Cancer Cell Int       Date:  2019-07-30       Impact factor: 5.722

5.  Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells.

Authors:  Chang-Cheng Zhao; Wen-Wei Yu; Ying-Jie Qi; Liang-Fei Xu; Zi-Ran Wang; Ya-Wen Qiang; Fan Ma; Xiao-Ling Ma
Journal:  Anticancer Drugs       Date:  2020-03       Impact factor: 2.389

Review 6.  Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression.

Authors:  Chloé Laplagne; Marcin Domagala; Augustin Le Naour; Christophe Quemerais; Dimitri Hamel; Jean-Jacques Fournié; Bettina Couderc; Corinne Bousquet; Audrey Ferrand; Mary Poupot
Journal:  Int J Mol Sci       Date:  2019-09-23       Impact factor: 5.923

7.  Immune-related biomarker risk score predicts prognosis in prostate cancer.

Authors:  Zezhen Liu; Jiehui Zhong; Chao Cai; Jianming Lu; Wenqi Wu; Guohua Zeng
Journal:  Aging (Albany NY)       Date:  2020-11-10       Impact factor: 5.682

8.  IL-1β secreted by macrophage M2 promotes metastasis of osteosarcoma via NF-κB/miR-181α-5p/RASSF1A/Wnt pathway.

Authors:  Zhi-Peng Han; Dong-Biao Liu; Liu-Qing Wu; Qin Li; Zheng-Guang Wang; Xiao-Fang Zang
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.